GB1050396A - - Google Patents
Info
- Publication number
- GB1050396A GB1050396A GB1050396DA GB1050396A GB 1050396 A GB1050396 A GB 1050396A GB 1050396D A GB1050396D A GB 1050396DA GB 1050396 A GB1050396 A GB 1050396A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compositions
- isogriseofulvin
- march
- griseofulvin
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 abstract 4
- FFKRWPQQTGWKIH-RBHXEPJQSA-N (2s,5'r)-7-chloro-3',4,6-trimethoxy-5'-methylspiro[1-benzofuran-2,6'-cyclohex-2-ene]-1',3-dione Chemical compound C[C@@H]1CC(OC)=CC(=O)[C@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 FFKRWPQQTGWKIH-RBHXEPJQSA-N 0.000 abstract 2
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 abstract 2
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 abstract 2
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 abstract 2
- 229960002867 griseofulvin Drugs 0.000 abstract 2
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- 201000002266 mite infestation Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US356044A US3325362A (en) | 1964-03-31 | 1964-03-31 | Isogriseofulvin providing higher griseofulvin blood levels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1050396A true GB1050396A (en:Method) |
Family
ID=33434723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1050396D Active GB1050396A (en:Method) | 1964-03-31 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US3325362A (en:Method) |
| DE (1) | DE1492032A1 (en:Method) |
| FR (1) | FR4238M (en:Method) |
| GB (1) | GB1050396A (en:Method) |
| NL (1) | NL6504095A (en:Method) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4151273A (en) * | 1974-10-31 | 1979-04-24 | The Regents Of The University Of California | Increasing the absorption rate of insoluble drugs |
| CA1146866A (en) * | 1979-07-05 | 1983-05-24 | Yamanouchi Pharmaceutical Co. Ltd. | Process for the production of sustained release pharmaceutical composition of solid medical material |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3128286A (en) * | 1964-04-07 | Process for preparing analogues | ||
| GB981521A (en) * | 1960-05-04 | 1965-01-27 | Glaxo Group Ltd | New analogues of griseofulvin and their preparation |
| US3090791A (en) * | 1960-07-25 | 1963-05-21 | Hoffmann La Roche | Synthesis of griseofulvin and analogues, and intermediates therefor |
| US3109849A (en) * | 1960-10-21 | 1963-11-05 | Glaxo Group Ltd | Process for preparing griseofulvin analogues |
-
0
- GB GB1050396D patent/GB1050396A/en active Active
-
1964
- 1964-03-31 US US356044A patent/US3325362A/en not_active Expired - Lifetime
-
1965
- 1965-03-19 DE DE19651492032 patent/DE1492032A1/de active Pending
- 1965-03-24 FR FR10526A patent/FR4238M/fr not_active Expired
- 1965-03-31 NL NL6504095A patent/NL6504095A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE1492032A1 (de) | 1969-02-27 |
| US3325362A (en) | 1967-06-13 |
| NL6504095A (en:Method) | 1965-10-01 |
| FR4238M (en:Method) | 1966-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8105292A1 (es) | Procedimiento para la obtencion de derivado de la difenilu- rea halogenosustituidos | |
| GB1221393A (en) | Improvements in or relating to hepato-protective drugs | |
| GB1050396A (en:Method) | ||
| GB1248429A (en) | 4-phenyl-quinazolinone derivative | |
| GB1049996A (en) | New medicine with anti-inflammatory and anti-rheumatic activity | |
| GB1126353A (en) | Isoquinolinobenzodiazepine derivatives | |
| GB1125924A (en) | Organic bismuth derivative | |
| IL39889A0 (en) | Inhalant compositions containing an anticholinergically active compound,and inhalers for the administration thereof | |
| IE36780B1 (en) | New pharmaceutical preparations | |
| GB1174362A (en) | Oral Medicants for Haemorrhoids. | |
| GB1021070A (en) | A new triazolone and a process for its preparation | |
| CA945544A (en) | 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS | |
| ES385521A1 (es) | Un metodo para producir un compuesto de azamorfinano. | |
| GB1279380A (en) | Improvements in or relating to hydantoins and compositions thereof | |
| GB1036059A (en) | Improvements in or relating to the inhibition of bacterial growth | |
| ES347203A1 (es) | Procedimiento para preparar composiciones de materia actva farmaceutica. | |
| ES345583A1 (es) | Un procedimiento para la preparacion de acidos 3-indolil a-ceticos. | |
| AU289517B2 (en) | Pharmaceutical compositions containing 2,4,6 trihydroxy benzonic acid and its salts | |
| CA810631A (en) | Dosage unit forms for the administration of medicaments | |
| GB1242742A (en) | Drug for stimulating the central nervous system | |
| AU226290B2 (en) | Composition containing an aminobenzodioxane or pharmaceutically acceptable salts thereof as active ingredient adapted for therapeutic administration | |
| Kobayashi | Therapeutic Effect of Sinomin (5-Methyl-3-Sulfanilamido Isoxazole) on Various Pyodermiasis | |
| AU281945B2 (en) | Therapeutic composition containing dimethylamino-3, 5, 6-trimethyl-pyrazine or its salts and process for preparation ofthe active ingredient | |
| AU3635658A (en) | Composition containing an aminobenzodioxane or pharmaceutically acceptable salts thereof as active ingredient adapted for therapeutic administration | |
| GB1316006A (en) | Pharmaceutically active chemical compound and an antitumourigenic preparation containing same |